JP2017078720A5 - - Google Patents

Download PDF

Info

Publication number
JP2017078720A5
JP2017078720A5 JP2016241059A JP2016241059A JP2017078720A5 JP 2017078720 A5 JP2017078720 A5 JP 2017078720A5 JP 2016241059 A JP2016241059 A JP 2016241059A JP 2016241059 A JP2016241059 A JP 2016241059A JP 2017078720 A5 JP2017078720 A5 JP 2017078720A5
Authority
JP
Japan
Prior art keywords
marker
amount
subject
ptsd
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016241059A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017078720A (ja
JP6371367B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017078720A publication Critical patent/JP2017078720A/ja
Publication of JP2017078720A5 publication Critical patent/JP2017078720A5/ja
Application granted granted Critical
Publication of JP6371367B2 publication Critical patent/JP6371367B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016241059A 2011-09-14 2016-12-13 心的外傷後ストレス障害（ｐｔｓｄ）のための診断用バイオマーカーを検出及び監視するため、並びに同障害の自殺型と非自殺型とを識別するためのプロセス及びキット Expired - Fee Related JP6371367B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161534560P 2011-09-14 2011-09-14
US61/534,560 2011-09-14
US201161569047P 2011-12-09 2011-12-09
US61/569,047 2011-12-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014530910A Division JP6061935B2 (ja) 2011-09-14 2012-09-14 心的外傷後ストレス障害（ｐｔｓｄ）のための診断用バイオマーカーを検出及び監視するため、並びに同障害の自殺型と非自殺型とを識別するためのプロセス及びキット

Publications (3)

Publication Number Publication Date
JP2017078720A JP2017078720A (ja) 2017-04-27
JP2017078720A5 true JP2017078720A5 (OSRAM) 2017-06-15
JP6371367B2 JP6371367B2 (ja) 2018-08-08

Family

ID=47884009

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014530910A Expired - Fee Related JP6061935B2 (ja) 2011-09-14 2012-09-14 心的外傷後ストレス障害（ｐｔｓｄ）のための診断用バイオマーカーを検出及び監視するため、並びに同障害の自殺型と非自殺型とを識別するためのプロセス及びキット
JP2016241059A Expired - Fee Related JP6371367B2 (ja) 2011-09-14 2016-12-13 心的外傷後ストレス障害（ｐｔｓｄ）のための診断用バイオマーカーを検出及び監視するため、並びに同障害の自殺型と非自殺型とを識別するためのプロセス及びキット

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014530910A Expired - Fee Related JP6061935B2 (ja) 2011-09-14 2012-09-14 心的外傷後ストレス障害（ｐｔｓｄ）のための診断用バイオマーカーを検出及び監視するため、並びに同障害の自殺型と非自殺型とを識別するためのプロセス及びキット

Country Status (7)

Country Link
US (2) US20150259740A1 (OSRAM)
EP (1) EP2756313A4 (OSRAM)
JP (2) JP6061935B2 (OSRAM)
CN (2) CN108593926A (OSRAM)
AU (2) AU2012308305B2 (OSRAM)
CA (1) CA2846625A1 (OSRAM)
WO (1) WO2013040502A2 (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8492107B2 (en) 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
US8943539B2 (en) 2007-11-21 2015-01-27 Rovi Guides, Inc. Enabling a friend to remotely modify user data
AU2009282117B2 (en) 2008-08-11 2016-05-12 Banyan Biomarkers, Inc. Biomarker detection process and assay of neurological condition
JP5909447B2 (ja) 2009-09-14 2016-04-26 バンヤン・バイオマーカーズ・インコーポレーテッド ニューロン損傷診断のためのマイクロｒｎａ、自己抗体およびタンパク質マーカー
US20140018299A1 (en) * 2012-07-10 2014-01-16 Banyan Biomarkers, Inc. Method and device to detect, monitor and promote neural regeneration and improvement of cognitive function in a subject suffering from neural injury
WO2015066211A1 (en) * 2013-10-29 2015-05-07 Banyan Biomarkers, Inc. Uch-l1 isoforms, assays and devices for detection of a neurological condition
US11085934B2 (en) 2015-10-08 2021-08-10 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Biomarkers for diagnosing post traumatic stress disorder
WO2018081649A1 (en) 2016-10-28 2018-05-03 Banyan Biomarkers, Inc. Antibodies to ubiquitin c-terminal hydrolase l1 (uch-l1) and glial fibrillary acidic protein (gfap) and related methods
EP3327134A1 (en) * 2016-11-28 2018-05-30 Carsten Korth Method and biomarkers for in vitro diagnosis of mental disorders
EP3480597A1 (en) * 2017-11-06 2019-05-08 Stalicla S.A. Biomarker assay for use in monitoring autism
US20210041448A1 (en) * 2018-04-19 2021-02-11 The University Of Tokyo Method and kit for assisting diagnosis of disease in subject
WO2020159965A1 (en) * 2019-01-30 2020-08-06 University Of South Florida Method for detection and analysis of cerebrospinal fluid associated ube3a
CN115993387A (zh) * 2021-10-20 2023-04-21 南开大学 一种抑郁症标志物的评估方法及其应用
CN117451995A (zh) * 2021-12-06 2024-01-26 上海市精神卫生中心（上海市心理咨询培训中心） 用于预测应激后精神心理症状发生的免疫检测试剂盒及应用
KR20250130624A (ko) * 2022-12-22 2025-09-02 트루지노믹스 헬스 인크. Ptsd 및 주요 우울증 식별을 위한 유전적 바이오마커
WO2025166069A1 (en) * 2024-01-30 2025-08-07 Trugenomix Health Inc. A novel biomarker for the identification of ptsd

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004135667A (ja) * 2002-09-27 2004-05-13 Japan Science & Technology Agency 血液を用いた統合失調症の診断方法
JP2006518206A (ja) * 2003-02-21 2006-08-10 ノバルティス アクチエンゲゼルシャフト 処置中の自殺傾向を予測するための方法
WO2005106038A2 (en) * 2004-04-15 2005-11-10 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
WO2006013561A2 (en) * 2004-08-02 2006-02-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions and methods for diagnosing and treating post traumatic stress disorder
CN101410518A (zh) * 2006-03-24 2009-04-15 诺瓦提斯公司 治疗HPV感染的dsRNA组合物和方法
EP1873527A1 (en) * 2006-06-30 2008-01-02 Schwarz Pharma Ag Method for identifying CRMP modulators
DE102007022669A1 (de) * 2007-05-11 2008-11-20 Carsten Dr. Korth Verwendung von CRMP1 als Marker für chronisch psychiatrische Erkrankungen
US20090048288A1 (en) * 2007-08-13 2009-02-19 H. Lundbeck A/S Method of treating stress-mediated depression
CA2704786C (en) * 2007-11-02 2019-04-09 Cornell University Materials and methods for gene mediated therapy of psychiatric disorders
AU2009212463A1 (en) * 2008-02-04 2009-08-13 Banyan Biomarkers, Inc. Process to diagnose or treat brain injury
CA2717763A1 (en) * 2008-03-04 2009-09-11 John Bilello Diagnosing and monitoring depression disorders based on multiple biomarker panels
EP2108657A1 (en) * 2008-04-08 2009-10-14 DKFZ Deutsches Krebsforschungszentrum Peptides for inhibiting the HPV-E6 oncoprotein
EP3586923B1 (en) * 2008-07-14 2021-06-16 Arizona Board Of Regents For And On Behalf Of Arizona State University Devices for modulating cellular activity using ultrasound
WO2010056897A1 (en) * 2008-11-12 2010-05-20 University Of Utah Research Foundation Autism associated genetic markers
US8715928B2 (en) * 2009-02-13 2014-05-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Molecular-based method of cancer diagnosis and prognosis
US20120269765A1 (en) * 2009-07-24 2012-10-25 Garcia K Christopher Cytokine compositions and methods of use thereof
SG179038A1 (en) * 2009-09-08 2012-04-27 Lab Corp America Holdings Compositions and methods for diagnosing autism spectrum disorders
JP2013524220A (ja) * 2010-04-01 2013-06-17 バンヤン・バイオマーカーズ・インコーポレイテッド 神経毒性を検出するためのマーカーおよびアッセイ

Similar Documents

Publication Publication Date Title
JP2017078720A5 (OSRAM)
González‐Gualda et al. A guide to assessing cellular senescence in vitro and in vivo
Belgrave et al. Assessment of serum amyloid A testing of horses and its clinical application in a specialized equine practice
Gregory et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
US11125745B2 (en) Magnetic electrochemical sensing
JP7485391B2 (ja) 治療剤選択のためのシグナル伝達経路活性の測定方法
DK2324360T3 (en) BIOMARKET DETECTION METHOD AND ASSAY OF NEUROLOGICAL CONDITION
JP2024056806A (ja) 外傷性脳損傷を診断及び査定するための、新規のバイオマーカー及び方法
Zoltewicz et al. Characterization of antibodies that detect human GFAP after traumatic brain injury
JP2018119975A (ja) 発癌性融合タンパク質を検出するための近接媒介性アッセイ
Nicholls et al. Characterization of TauC3 antibody and demonstration of its potential to block tau propagation
CN103959067A (zh) 用于检测和监测用于创伤后应激障碍（ptsd）的诊断生物标志物以及用于区分自杀式与非自杀式障碍的方法和试剂盒
Shah et al. Calibration-free concentration analysis of protein biomarkers in human serum using surface plasmon resonance
US20160123965A1 (en) Reagents, methods and devices to prevent aggregation in particle based tests for the detection of multimeric target molecules
Shaw The use and potential of pNF-H as a general blood biomarker of axonal loss: an immediate application for CNS injury
Hatano et al. α-Synuclein: a promising biomarker for Parkinson’s disease and related disorders
Chang et al. Label-free colorimetric aptasensor for IgE using DNA pseudoknot probe
KR20140042331A (ko) 인지장애 질환 진단용 다중 마커 및 그 용도
Liu et al. Identification of PHB2 as a potential biomarker of luminal a breast cancer cells using a cell-specific aptamer
Tumani et al. Biochemical markers of autoimmune diseases of the nervous system
Li et al. Annexin A5 protein expression is associated with the histological differentiation of uterine cervical squamous cell carcinoma in patients with an increased serum concentration
CN107110848B (zh) 以脱氧羟腐胺缩赖氨酸合酶基因作为指标使用的动脉硬化及癌的检测方法
JP2022130598A (ja) 血液から癌を診断する方法
US20230017081A1 (en) Biosensor for detection of sars-cov-2 spike glycoprotein and related methods
Saul et al. Distinct senotypes in p16-and p21-positive cells across human and mouse aging tissues